EME Equity Market – February 2025 Poland outperforms, again; Türkiye declines. The MSCI EM Europe Index advanced by 3.1% in EUR terms and 2.9% mom in USD terms in February. The Polish WIG20 was, once again, the best performer, adding 7.3% mom in February; followed by the Czech PX Index (+6.1% mom); while Greece (+3.8% mom), Hungary (+3.5% mom) and Romania (+3.0% mom) all reported rather similar performances. The Turkish ISE30 was the worst performer, declining 4.5% mom.
A director at Medicover AB bought 9,700 shares at 206.500SEK and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
HEADLINES: • MOL: there’s gain in the mundane (stays BUY) • Tofas: very weak set of results in 4Q24 NEGATIVE • Orange Polska: 4Q24 – EBITDAaL up 7% yoy, 6% above the consensus; 2025E guidance in line with expectations POSITIVE • ADNOC Drilling: 4Q24 results beat expectations POSITIVE • TBC Bank: 4Q24 results and conference call • Isbank: 4Q24 results and 2025E guidance highlights NEUTRAL • Medicover: takeaways from the 4Q24 earnings call • 11 bit studios: delays release of The Alters NEGATIVE • ...
HEADLINES: • Medicover: 4Q results a small beat; appoints new CEO POSITIVE • Hungary macro: January inflation surprises on the upside • EME Strategy: MSCI – February review results • ADNOC Drilling: 4Q24E results (due out tomorrow) NEUTRAL • OTE: 4Q24E results preview – 1% yoy adjusted EBITDA growth expected (due on 26 February) • Banca Transilvania: 4Q24E preview (due on 28 February)
HEADLINES: • Santander BP: 4Q24 results imply solid dividend potential, but share overhang remains a risk in the near term POSITIVE • Asseco Poland: TSS acquires 14.84% stake in Asseco Poland NEUTRAL • Trade Estates: Fourlis sells 16% stake at EUR 1.5/share • CEZ: to sell 15% stake in Veolia CR heating business NEUTRAL • Auto Partner: January sales growth at a limited 9% yoy NEGATIVE • Medicover: 4Q24E preview (due on 12 February) • Short News (CBF, SHO)
HEADLINES: • Romania macro: important comments ahead of the second round of elections • Poland macro: NBP extends the pause • PGE: CEO comments on strategy, coal assets and nuclear power plant NEUTRAL • Hungary macro: Magyar aims to unlock EU funds and enter the Eurozone • Türkiye macro: November inflation shows key challenge remains in food prices • WOOD's Winter Wonderland EME Conference 2024 • Asseco Poland: postcard from Prague • Text: postcard from Prague • Aquila Part Prod Com S.A.: postca...
EME Equity Market – October 2024 A red October for the EME indices, only Czechia in positive territory. The MSCI EM Europe Index declined by 6.0% in EUR terms and 8.4% in USD terms in October. The Czech PX index was the only one spared, adding 1.3% mom in EUR terms. Türkiye was battered the most, with the Turkish ISE30 declining by 7.3% mom in EUR terms, followed closely by the Polish WIG20 (-6.7% mom in EUR terms). Greece fell 4.8% mom in EUR terms, while the Hungarian BUX index lost 2.7% mom i...
HEADLINES: • Erste Bank: 3Q24 results – strong NII delivery • mBank: underlying 3Q34 business delivery in line; beat on headline net profit due to tax charges NEUTRAL • ING BSK: 3Q24 results – minor miss on high credit risk charges, as corporate NPL ratio surges NEUTRAL • Jeronimo Martins: beat in 3Q24, Biedronka at -2% lfl and stable margin erosion; price war continues POSITIVE • Komercni Banka: 3Q24 results – net profit largely in line with expectations • Medicover: 3Q24 operating numbers in l...
HEADLINES: • Asseco Poland: profitability rebound slower than expected (downgraded to HOLD) • EME Macro/Strategy: macro all-in-one (21-27 October) • Georgia macro: early takes following the parliamentary election • Arcelik: weak set of results in 3Q24 NEGATIVE • Solutions by STC: 3Q24 results NEGATIVE • Budimex: 3Q24 EBIT marginally above our and the market's expectations NEUTRAL • Cimsa: 3Q24 conference call takeaways • PKO BP: three of four largest minority shareholders act jointly to call EGM...
HEADLINES: • Kruk: announces PLN 356m of net profit in 3Q24 POSITIVE • Allegro: introduction of spirits suspended NEGATIVE • Medicover: seeking approval to acquire laboratories in Romania • Solutions by STC: signs contract with Saudi Telecom Company • Erste Bank: 3Q24E preview (due on 31 October) • cyber_Folks: 3Q24E results preview – 24% yoy adjusted EBITDA growth (due on 13 November) • Auto Partner: 3Q24E EBITDA down 6% yoy (due on 19 November) • Short News (4iG)
HEADLINES: • Medicover: private healthcare pioneer keeps on rolling (BUY - initiation of coverage) • OTE: safe dividend play (upgraded to BUY) • National Bank of Greece: HFSF launches the sale of a 10% stake in NBG NEUTRAL • PCF Group: 2Q24 results in negative territory, below our expectations NEGATIVE • mBank: issues traditional profit warning related to the CHF mortgage saga, ahead of 3Q24E results NEUTRAL • InPost: 4.9% price hike for Allegro NEUTRAL • Allegro: introduction of spirits from 21...
We initiate coverage of Medicover with a BUY rating and a price target (PT) of SEK 238/share. Medicover provides healthcare and diagnostic services across several European markets - mainly Poland, Germany and Romania - as well as India. It offers a well-tested proposition: healthcare services and facilities that are “a cut above” those offered by the State systems, at prices accessible to the middle classes. The business generated a 2019-23 revenues CAGR of 20%; excluding acquisitions, the top l...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.